triphosphoric acid has been researched along with Alloxan Diabetes in 6 studies
triphosphoric acid: used as water softener, peptizing agent, emulsifier & dispersing agent; ingredient of cleansers; meat preservative; RN given refers to parent cpd; structure
| Excerpt | Relevance | Reference |
|---|---|---|
| " The combination dosage form increased the blood glucose lowering extent of insulin and blood insulin level compared with nanoparticles or beads alone." | 1.48 | Alginate-C18 Conjugate Nanoparticles Loaded in Tripolyphosphate-Cross-Linked Chitosan-Oleic Acid Conjugate-Coated Calcium Alginate Beads as Oral Insulin Carrier. ( Alfatama, M; Lim, LY; Wong, TW, 2018) |
| "Gliclazide is a second generation of hypoglycemic sulfonylurea and acts selectively on pancreatic beta cell to control diabetes mellitus." | 1.35 | Applying the Taguchi design for optimized formulation of sustained release gliclazide chitosan beads: an in vitro/in vivo study. ( Minayian, M; Rahdari, N; Tavakoli, N; Varshosaz, J, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| He, Z | 1 |
| Santos, JL | 1 |
| Tian, H | 1 |
| Huang, H | 1 |
| Hu, Y | 1 |
| Liu, L | 1 |
| Leong, KW | 1 |
| Chen, Y | 1 |
| Mao, HQ | 1 |
| Alfatama, M | 1 |
| Lim, LY | 1 |
| Wong, TW | 1 |
| Barbari, GR | 1 |
| Dorkoosh, F | 1 |
| Amini, M | 1 |
| Bahari Javan, N | 1 |
| Sharifzadeh, M | 1 |
| Atyabi, F | 1 |
| Balalaie, S | 1 |
| Rafiee Tehrani, N | 1 |
| Rafiee Tehrani, M | 1 |
| Varshosaz, J | 1 |
| Tavakoli, N | 1 |
| Minayian, M | 1 |
| Rahdari, N | 1 |
| Barakat, NS | 1 |
| Almurshedi, AS | 1 |
| NORDLIE, RC | 1 |
| ARION, WJ | 1 |
6 other studies available for triphosphoric acid and Alloxan Diabetes
| Article | Year |
|---|---|
Scalable fabrication of size-controlled chitosan nanoparticles for oral delivery of insulin.
Topics: Administration, Oral; Animals; Biological Transport; Blood Glucose; Caco-2 Cells; Chitosan; Diabetes | 2017 |
Alginate-C18 Conjugate Nanoparticles Loaded in Tripolyphosphate-Cross-Linked Chitosan-Oleic Acid Conjugate-Coated Calcium Alginate Beads as Oral Insulin Carrier.
Topics: Administration, Oral; Alginates; Animals; Blood Glucose; Chitosan; Diabetes Mellitus, Experimental; | 2018 |
Synthesis and characterization of a novel peptide-grafted Cs and evaluation of its nanoparticles for the oral delivery of insulin, in vitro, and in vivo study.
Topics: Administration, Oral; Amino Acid Sequence; Animals; Blood Glucose; Cell-Penetrating Peptides; Chitos | 2018 |
Applying the Taguchi design for optimized formulation of sustained release gliclazide chitosan beads: an in vitro/in vivo study.
Topics: Animals; Blood Glucose; Chemistry, Pharmaceutical; Chitosan; Cross-Linking Reagents; Delayed-Action | 2009 |
Design and development of gliclazide-loaded chitosan microparticles for oral sustained drug delivery: in-vitro/in-vivo evaluation.
Topics: Administration, Oral; Animals; Blood Glucose; Calorimetry, Differential Scanning; Chitosan; Cross-Li | 2011 |
LIVER MICROSOMAL GLUCOSE 6-PHOSPHATASE, INORGANIC PYROPHOSPHATASE, AND PYROPHOSPHATE-GLUCOSE PHOSPHOTRANSFERASE. 3. ASSOCIATED NUCLEOSIDE TRIPHOSPHATE- AND NUCLEOSIDE DIPHOSPHATE-GLUCOSE PHOSPHOTRANSFERASE ACTIVITIES.
Topics: Animals; Cytosine Nucleotides; Diabetes Mellitus, Experimental; Diphosphates; Glucose; Glucose-6-Pho | 1965 |